Home > Search Clinical Trials > Women’s Health (Infertility, Menopause, Etc.)
Clinical Trials: Women’s Health (Infertility, Menopause, Etc.)
IRB No. 11-057-6 (Dr. Cheryl Oncken, PI): Nicotine Replacement for Smoking Cessation during Pregnancy
This is a clinical trial to determine if the nicotine inhaler in combination with counseling will help pregnant women quit smoking, and whether it is safe when compared to placebo (an inactive inhaler). The primary goals are: to examine the efficacy of the nicotine inhaler compared to a matched placebo for smoking cessation and reduction among pregnant smokers; to compare the nicotine inhaler with placebo on overall nicotine exposure (i.e., serum cotinine) and on birth outcomes (i.e., birth weight and gestational age); to identify factors that determine which women benefit most from the use of nicotine inhaler for smoking cessation during pregnancy; to explore mechanisms by which the nicotine inhaler increases birth weight and gestational age
IRB No. 11-168-1 (Dr. Lawrence Engmann, PI): A Prospective Comparison of Transcriptional Profiling of Luteal Phase Endometrial Biopsies After Ovarian Stimulation with Gonadotropins and Induction of Oocyte Maturation with a Gonadotropin Releasing Hormone (GnRH) Agonist or Human Chorionic Gonadotropins (hCG)
The purpose of the study is to compare gene expression profiles in endometrial biopsies taken during the window of implantation after triggers of oocyte maturation using GnRH agonist or hCG. The hypothesis is that the reduced rate of embryo implantation in some women triggered with GnRH agonist is due to alter gene expression in the endometrium.
IRB No. 14-197-6 (Dr. Damion Grasso, PI): The Influence of Prenatal Exposure to Stress on the DNA Methylation Status of FKBP5 in Newborns
Understanding the impact of prenatal maternal stress (PNMS) on child development is needed to identify at-risk children at the earliest possible time point and to design and implement effective interventions. One of the genes involved in the stress response pathway is FKBP5 (FK506 binding protein 5). The FKBP5 protein is a critical component of a negative feedback loop that functions to terminate the stress response at the cellular level by decreasing ligand binding and blocking translocation of the glucocorticoid receptor complex into the nucleus. Emerging data on FKBP5 suggests one potential pathway by which early, chronic childhood trauma exposure may lead to emotional and behavioral problems later in life. This study seeks to understand how the in utero exposure to domestic violence can impact ability of this gene to function properly.
IRB No. O18-075-2 (Dr. George Kuchel, PI): Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture
Study description not available